Steady-state brain glucose concentrations during hypoglycemia in healthy humans and patients with type 1 diabetes

KCC van de Ven, M van der Graaf, CJ Tack… - Diabetes, 2012 - Am Diabetes Assoc
KCC van de Ven, M van der Graaf, CJ Tack, A Heerschap, BE de Galan
Diabetes, 2012Am Diabetes Assoc
The objective of this study was to investigate the relationship between plasma and brain
glucose levels during euglycemia and hypoglycemia in healthy subjects and patients with
type 1 diabetes mellitus (T1DM). Hyperinsulinemic euglycemic (5 mmol/L) and
hypoglycemic (3 mmol/L)[1-13C] glucose clamps were performed in eight healthy subjects
and nine patients with uncomplicated T1DM (HbA1c 7.7±1.4%). Brain glucose levels were
measured by 13C magnetic resonance spectroscopy. Linear regression analysis was used …
The objective of this study was to investigate the relationship between plasma and brain glucose levels during euglycemia and hypoglycemia in healthy subjects and patients with type 1 diabetes mellitus (T1DM). Hyperinsulinemic euglycemic (5 mmol/L) and hypoglycemic (3 mmol/L) [1-13C]glucose clamps were performed in eight healthy subjects and nine patients with uncomplicated T1DM (HbA1c 7.7 ± 1.4%). Brain glucose levels were measured by 13C magnetic resonance spectroscopy. Linear regression analysis was used to fit the relationship between plasma and brain glucose levels and calculate reversible Michaelis-Menten (MM) kinetic parameters. Brain glucose values during euglycemia (1.1 ± 0.4 μmol/g vs. 1.1 ± 0.3 μmol/g; P = 0.95) and hypoglycemia (0.5 ± 0.2 μmol/g vs. 0.6 ± 0.3 μmol/g; P = 0.52) were comparable between healthy subjects and T1DM patients. MM kinetic parameters of combined data were calculated to be maximum transport rate/cerebral metabolic rate of glucose (Tmax/CMRglc) = 2.25 ± 0.32 and substrate concentration at half maximal transport (Kt) = 1.53 ± 0.88 mmol/L, which is in line with previously published data obtained under hyperglycemic conditions. In conclusion, the linear MM relationship between plasma and brain glucose can be extended to low plasma glucose levels. We found no evidence that the plasma to brain glucose relationship or the kinetics describing glucose transport over the blood–brain barrier differ between healthy subjects and patients with uncomplicated, reasonably well-controlled T1DM.
Am Diabetes Assoc